Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations |
---|---|
6/30/2025 | $ -171.48M |
3/31/2025 | $ -175.12M |
12/31/2024 | $ -162.39M |
9/30/2024 | $ -155.79M |
6/30/2024 | $ -158.43M |
3/31/2024 | $ -159.5M |
12/31/2023 | $ -163.69M |
9/30/2023 | $ -163.33M |
6/30/2023 | $ -162.74M |
3/31/2023 | $ -167.91M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Mar 31, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | $ -406M |
max | $ 506.5M |
average | $ 57.96M |
median | $ 10.78M |
std | $ 141.66M |